7 Nov

Why ValueAct Capital discloses 5.7% stake in Agrium

WRITTEN BY Samantha Nielson

ValueAct Capital’s stake in Agrium

Shares in Agrium (AGU) rallied at the end of October after activist investor Jeffrey Ubben’s ValueAct Capital disclosed a 5.7% stake in the company. A 13D filing was made on October 24. The filing stated that the hedge fund acquired 8.19 million Agrium shares.

The fund said that the stake was acquired for “investment purposes.” However, news reports speculated that ValueAct will play more than a passive role in Agrium. In this series, we’ll evaluate ValueAct’s interest in Agrium. We’ll also highlight updates from the the Canadian fertilizer producer’s latest 3Q14 results.

Why ValueAct Capital discloses 5.7% stake in Agrium

Company overview

Agrium is a major retail supplier of agricultural products and services in North and South America. It’s a leading global producer and marketer of agricultural nutrients and industrial products. It produces and markets three primary groups of nutrients:

  1. nitrogen,
  2. phosphate and
  3. potash

It also produces controlled-release fertilizers and micronutrients.

Agrium’s wholesale segment produces, markets, and distributes nitrogen, phosphate, and potash for agricultural and industrial customers around the world.

Agrium Retail is the largest global retailer of crop input products and services. It provides growers with nutrients, seed, crop protection products, and advisory and application services. Agrium’s retail unit accounted for 43% of adjusted earnings before interest, tax, depreciation, and amortization (or EBITDA) in 2013. Retail is its largest segment.

Potash Corporation of Saskatchewan (POT)—or PotashCorp, Mosaic (MOS), and CF Industries (CF) are some of Agrium’s peers in the wholesale business. However, these competitors don’t have a retail business. Agrium also has exposure to the VanEck Vectors Agribusiness ETF (MOO). It has a 4.4% share.

ValueAct’s activist targets

ValueAct is based in San Francisco. It manages more than $14 billion on behalf of several institutional and individual investors. The fund was founded in 2000 by Jeffrey Ubben and George Hamel, Jr. One of its notable targets is Microsoft.

ValueAct revealed its $2 billion position in Microsoft last year. It was instrumental in CEO Steve Ballmer’s exit. Mason Morfit, president of ValueAct Capital, was appointed to Microsoft’s board of directors in March. The fund has also nominated directors in Adobe Systems Inc. and Motorola Solutions Inc.

Other known targets include Valeant Pharmaceuticals International Inc. and Sara Lee Corp. The fund is long-term oriented. It works with the company’s management and board to bring about change from the inside.

Latest articles

Verizon Communications stock (VZ) closed down 2.09% on Tuesday after the leading US mobile carrier reported mixed results for the first quarter of 2019 before the market bell yesterday.

24 Apr

Nokia’s Patent Business Is Put On the Spot

WRITTEN BY Rachel Gunter

Several European auto companies want Nokia’s (NOK) patent business subjected to an antitrust probe.

The first-quarter semiconductor earnings season has begun, and the stock market is showing bullish sentiment as investors buy ahead of earnings releases.

Netflix (NFLX) is working its way through a series of price increases in several markets, including the United States and parts of Europe.

Netflix (NFLX) is aiming to add 14.6 million paying subscribers in the first six months of 2019.

Earlier today, the second-largest US automaker, Ford Motor Company (F), announced a plan to invest $500 million in Plymouth-based automotive company Rivian.